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Available online 2 February 2016Little is known how lincRNAs are involved in skeletal myogenesis. Here we describe the discovery and functional an-
notation of Linc-YY1, a novel lincRNA originating from the promoter of the transcription factor (TF) Yin Yang 1 (YY1).
Starting fromwhole transcriptome shotgun sequencing (a.k.a. RNA-seq) data frommuscle C2C12 cells, a series of bio-
informatics analysiswas applied towards the identiﬁcation of hundreds of high-conﬁdence novel lincRNAs. Genome-
wide approacheswere then employed to demonstrate that Linc-YY1 functions to promotemyogenesis through asso-
ciatingwithYY1and regulatingYY1/PRC2 transcriptional activity in trans. Herewedescribe thedetails of theChIP-seq,
RNA-seq experiments, and data analysis procedures associated with the study published by Zhou and colleagues in
theNature Communications Journal in 2015 Zhouet al. (2015) [1]. The datawas deposited onNCBI's Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) with accession number GSE74049.
© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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array typeIllumina HiSeq 1500, Illumina Hiseq 2000, Illumina GA IIxata format Raw data: FASTQ ﬁles
Processed data: BEDGRAPH, TXTxperimental
factorsMyoblast vs myotubexperimental
featuresUsing RNA-seq, we identiﬁed hundreds of high conﬁdence
novel lincRNAs in skeletal muscle. Among these lincRNAs, one
near the YY1 transcription factor caused our attention, which
we named Linc-YY1. We then used ChIP-seq and RNA-seq to
investigate the function of this novel lincRNA during
myogenesis.onsent NA
mple source
locationManassas, VA, USA1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74049.Health Sciences, The Chinese
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en access article under the CC BY-NC2. Experimental design, materials, and methods
2.1. Cell culture
Mouse C2C12 myoblasts cell line was purchased from American
Type Culture Collection (ATCC). Themyoblastsweremaintain in growth
medium (DMEM, 10%FBS and 1% Penicillin/Streptomycin), and induced
to myotubes by culturing in differentiation medium (DMEM, 2% horse
serum and 1% Penicillin/Streptomycin).
2.2. ChIP assays and sequencing experiments
ChIP assays were performed as previously described [2,3]. About
2× 107 C2C12 cells and5 μg of antibodieswere used in one immunopre-
cipitation. The antibodies include YY1 (Santa Cruz Biotechnology), Ezh2
(Active Motif), Eed (Millipore), trimethyl-histone H3-K27 (Millipore),
or normal mouse IgG (Santa Cruz Biotechnology) as a negative control.
For library construction, we used a protocol as described before [4].
Brieﬂy, the immunoprecipitated DNA (~10 ng) were end-repaired,
and A-nucleotide overhangs were then added, followed by adapter
ligation, PCR enrichment, size selection and puriﬁcation. The puriﬁed
DNA library products were evaluated using Bioanalyzer (Agilent) and
SYBR qPCR and diluted to 10 nM for sequencing on Illumina Hi-seq
2000 sequencer (YY1) (pair-end with 50 bp) or Illumina Genome Ana-
lyzer II sequencer (Ezh2, Eed and H3K27me3) (pair-end with 36 bp).-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Sequencing and mapping information for the experiments.
Type Sample Treatment Raw reads Pre-processed⁎ Mapped reads Mappability (%)
ChIP-seq Ezh2 Vector transfected 33,033,076 NA 22,480,371 68.1
ChIP-seq EED Vector transfected 42,772,454 NA 32,563,476 76.1
ChIP-seq H3K27me3 Vector transfected 42,897,641 NA 33,224,324 77.5
ChIP-seq IgG Vector transfected 46,757,140 NA 35,189,696 75.3
ChIP-seq Yy1 Linc-YY1 transfected 120,778,675 28,875,468 22,368,411 77.5
ChIP-seq Ezh2 Linc-YY1 transfected 45,143,782 NA 35,378,560 78.4
ChIP-seq EED Linc-YY1 transfected 45,229,883 NA 34,536,361 76.4
ChIP-seq H3K27me3 Linc-YY1 transfected 46,306,903 NA 35,814,707 77.3
ChIP-seq IgG Linc-YY1 transfected 38,713,272 NA 27,863,812 72.0
RNA-seq siNC Negative control oligo transfected 248,983,238 112,409,997 94,952,575 84.5
RNA-seq siLinc-YY1 siLinc-YY1 oligo transfected 275,819,571 64,514,698 52,448,804 81.3
⁎ The preprocessing procedure is only performed on sampleswith high duplication rate designed to remove the duplicated reads while not for others with low duplication rate (shown
as ‘NA’).
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twice. A data analysis pipeline CASAVA 1.8 (Illumina) was employed
to perform the initial bioinformatics analysis (base calling). Table 1
lists all the experiments that we had performed. For MB YY1, we
performed two biological replicates with the antibody SC-1703 and
a third biological replicate with a second antibody AB58066. We
also performed two technical replicates for each antibody (run 1
and run 2).2.3. Read alignment and peak calling
The sequenced reads were mapped to the mouse reference genome
(UCSC mm9, non-repeat-masked) using SOAP2 [5] (v2.20) allowing a
maximum of two mismatches and only the uniquely aligned reads
were kept. The sequencing andmapping information from each dataset
were shown in Table 1. The protein-DNA binding peaks were identiﬁed
using Model-based Analysis for ChIP-seq (MACS [6], v1.4.2) with IgG
control sample as background. The p-value cutoff was set as 10−5 to
call high-conﬁdence binding sites.2.4. Whole transcriptome sequencing experiments
Preparation of RNA-seq libraries for sequencing on the Illumina plat-
forms was carried out using the RNA-Seq Sample Preparation Kit
(catalog number RS-930-1001) according to the manufacturer's
standard protocol. Brieﬂy, puriﬁed RNA was fragmented via incubation
for 5 min at 94'C with the Illumina supplied fragmentation buffer. The
ﬁrst strand of cDNA was next synthesized by reverse transcription
using random oligo primers. Second-strand synthesis was conducted
by incubation with RNase H and DNA polymerase I. The resulting
double-stranded DNA fragments were subsequently end-repaired and
A-nucleotide overhangs were added by incubation with Taq Klenow
lacking exonuclease activity. After the attachment of anchor sequences,
fragments were PCR ampliﬁed using Illumina-supplied primers and
loaded onto the Hiseq 2000 or GAIIx ﬂow cell. DNA clusters were
generated with an Illumina cluster station with Paired-End Cluster
Generation Kit v2 (Illumina), followed by 50 (or 26 bp)*2 cycles of
sequencing on sequencer with Sequencing Kit v3 (Illumina).
Genome Analyzer Sequencing Control Software (SCS) v2.5, which
could perform real-time image analysis and base calling, was used
to carry out the image processing and base calling during the chem-
istry and imaging cycles of a sequencing run. The default parameters
within the data analysis software (SCS v2.5) from Illumina were used
to ﬁlter poor-quality reads. In the default setting, a read would be re-
moved if a chastity of b0.6 is observed on two or more bases among
the ﬁrst 25 bases.2.5. Transcriptome assembly and novel lincRNA identiﬁcation
To generate a comprehensive catalog of lincRNAs inmuscle cells, we
applied an integrated analysis on RNA-seq data generated by Trapnell
et al. [7] and our own RNA-seq data from proliferating and differentiat-
ing C2C12 cells. The raw sequencing reads were aligned to the mouse
reference genome (UCSC mm9) using Tophat (v2.0.4) [7], during
which procedure the UCSC gene annotation ﬁle downloaded from
Cufﬂinks website (http://cole-trapnelllab.github.io/cufﬂinks/igenome_
table/index.html) was used (the ‘-G’ option). The transcriptome assem-
blywas thenperformed usingCufﬂinks (v2.0.4) [7], and a total of 46,627
transcripts were obtained. Then sebnif (v1.2.2) [8] was employed to
identify the high-conﬁdence novel lincRNAs. In this procedure, the an-
notated genes, transcript size, expression level and coding potential
were all considered. As a result, a total of 2413 novel lincRNAs were
identiﬁed. After further annotating each of themwith features including
K4-K36 domain, EST tag and MyoD binding, a stringent set of 158
lincRNAs were obtained.2.6. Differentially expressed genes analysis
To detect the differentially expressed genes between siNC- and
siLinc-YY1-transfected C2C12 cells, the raw RNA-seq data were ﬁrst
preprocessed (adapter trimming and duplicate removing using in-
house programs) and then aligned to the reference genome (UCSC
mm9) using Tophat (version 2.0.4), during which procedure the UCSC
gene annotation ﬁle downloaded from Cufﬂinks website (http://cole-
trapnelllab.github.io/cufﬂinks/igenome_table/index.html) was used
(the ‘-G’ option). The sequencing and mapping information were
shown in Table 1. Cuffdiff (version 2.0.4) [7] was then applied on the
aligned data set against the RefSeq gene annotation, to determine differ-
entially expressed genes with a ‘signiﬁcant’ status. The GO analysis of
the differentially expressed genes was performed using DAVID (http://
david.abcc.ncifcrf.gov/).References
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